Featured

InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid

http://www.cannabisfn.com/inmed-announces-positive-pre-clinical-data-ocular-hydrogel-formulation-using-biosynthesized-cannabinoid/

VANCOUVER , Oct. 24, 2017 /CNW/ – InMed Pharmaceuticals, Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF ), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies , announced today results from a study co-sponsored by InMed (Dr. Sazzad Hossain , Chief Scientific Officer) and the University of British Columbia (laboratories […]

The post InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid appeared first on CannabisFN.

Show More

Brian Wroblewski

Brian Wroblewski has a passion for writing, travel, food and family. Since working in and around the cannabis industry since 2008, Brian brings a unique perspective to the cannabis journalism space. With a focus on emerging brands, moving the cannabis industry forward and an undeniable passion for truth in business and journalism, find some of Brian's posts across the web on digital marketing, cannabis and a variety of different topics.

Related Articles

Back to top button
Close
Close